Pharmacotherapy for Pediatric Generalized Anxiety Disorder: A Systematic Evaluation of Efficacy, Safety and Tolerability

被引：0
|
作者：
Eric T. Dobson
Jeffrey R. Strawn
机构：
[1] University of Cincinnati,Department of Psychiatry and Behavioral Neuroscience
[2] College of Medicine,Department of Psychiatry
[3] Cincinnati Children’s Hospital Medical Center,undefined
来源：
Pediatric Drugs | 2016年 / 18卷
关键词：
Anxiety Disorder; Generalize Anxiety Disorder; Sertraline; Social Anxiety Disorder; Duloxetine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：45 / 53
页数：8
相关论文
共 50 条
  • [21] Questionable Tolerability of Tiagabine in Generalized Anxiety Disorder
    Spielmans, Glen I.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (03) : 314 - 314
  • [22] Efficacy and Safety Limitations of Attention Deficit Hyperactivity Disorder Pharmacotherapy in Pediatric Patients
    Wigal, Sharon B.
    JOURNAL OF PEDIATRICS, 2009, 154 (05): : S13 - S21
  • [23] A flexible dose open label trial evaluating the efficacy and safety of quetiapine as adjunctive pharmacotherapy for the treatment of generalized anxiety disorder (GAD)
    Katzman, M. A.
    Vermani, M.
    Jacobs, L.
    Marcus, M.
    Lessard, S.
    Galarraga, W.
    Kong, B. Y.
    Struzik, L.
    Gendron, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S543 - S543
  • [24] Evidence-based pharmacotherapy of generalized anxiety disorder
    Baldwin, DS
    Polkinghorn, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2005, 8 (02): : 293 - 302
  • [25] Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder
    Dunayevich, Eduardo
    Erickson, Janelle
    Levine, Louise
    Landbloom, Ronald
    Schoepp, Darryle D.
    Tollefson, Gary D.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (07) : 1603 - 1610
  • [26] Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis
    Zareifopoulos, Nicholas
    Dylja, Irene
    ASIAN JOURNAL OF PSYCHIATRY, 2017, 26 : 115 - 122
  • [27] Efficacy and Tolerability of an mGlu2/3 Agonist in the Treatment of Generalized Anxiety Disorder
    Eduardo Dunayevich
    Janelle Erickson
    Louise Levine
    Ronald Landbloom
    Darryle D Schoepp
    Gary D Tollefson
    Neuropsychopharmacology, 2008, 33 : 1603 - 1610
  • [28] Pharmacotherapy Update: Pregabalin in the Treatment of Generalized Anxiety Disorder
    Montgomery, Stuart A.
    Kasper, Siegfried
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 189 - 202
  • [29] Optimizing pharmacotherapy of generalized anxiety disorder to achieve remission
    Pollack, MH
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 20 - 25
  • [30] Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin
    Both, Charlotte
    Kojda, Georg
    Lange-Asschenfeldt, Christian
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (01) : 29 - 38
12345